The antitumor CD8+ T cells exhibit preferential expression of PD-1 leading to their exhaustion and functional impairment, which in turns lead to attenuated tumor-specific immunity disseminating tumor progression [10,11]. This evidence concerns the gene CD8A and neoplasm.